SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001193125-14-118851
Filing Date
2014-03-27
Accepted
2014-03-27 17:31:06
Documents
1
Period of Report
2013-12-31
Effectiveness Date
2014-03-27

Document Format Files

Seq Description Document Type Size
1 NT 10-K d700872dnt10k.htm NT 10-K 25021
  Complete submission text file 0001193125-14-118851.txt   26265
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Filer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 000-52062 | Film No.: 14722679
SIC: 2834 Pharmaceutical Preparations